abstract |
The present invention provides an isolated peptide or fragment from SEQ ID NO: 45 that binds to HLA antigen and induces CTL (cytotoxic T lymphocyte, CTL). The peptide may comprise the above-mentioned amino acid sequence in which one, two, or a plurality of amino acid sequences have been deleted, or added. The present invention also provides a pharmaceutical composition comprising such peptides. The peptides of the present invention can be used for the diagnosis or treatment of cancer. |